Publication | Open Access

Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma

AsthmaInflammationAnti-inflammatoryAllergyMurine ModelImmunologyRespiratory InfectionChronic AsthmaMedicineClinical MicrobiologyAntimicrobial ResistanceBifidobacterium Breve